The Perception among Israeli Gastroenterologists Regarding Treatment of Patients with Biosimilar Medications.

Richter, Vered; Cohen, Daniel L; Bermont, Anton; Shalem, Tzippi; Broide, Efrat; Shirin, Haim

Richter, Vered; Cohen, Daniel L; Bermont, Anton; Shalem, Tzippi; Broide, Efrat; Shirin, Haim.

Afiliação

Richter V; The Gonczarowski Family Institute of Gastroenterology and Liver Disease, Shamir (Assaf Harofeh) Medical Center, Zerifin 70300, Israel.
Cohen DL; The Gonczarowski Family Institute of Gastroenterology and Liver Disease, Shamir (Assaf Harofeh) Medical Center, Zerifin 70300, Israel.
Bermont A; The Gonczarowski Family Institute of Gastroenterology and Liver Disease, Shamir (Assaf Harofeh) Medical Center, Zerifin 70300, Israel.
Shalem T; The Jecheskiel Sigi Gonczarowski Pediatric Gastroenterology Unit, Shamir (Assaf Harofeh) Medical Center, Zerifin 70300, Israel.
Broide E; The Jecheskiel Sigi Gonczarowski Pediatric Gastroenterology Unit, Shamir (Assaf Harofeh) Medical Center, Zerifin 70300, Israel.
Shirin H; Sackler School of Medicine, Tel Aviv University, Tel Aviv 39040, Israel.

Medicina (Kaunas) ; 59(3)2023 Mar 07.

Article em En | MEDLINE | ID: mdl-36984524

Assuntos

Medicamentos Biossimilares; Gastroenterologistas; Gravidez; Humanos; Feminino; Medicamentos Biossimilares/uso terapêutico; Estudos Transversais; Israel; Percepção

Palavras-chave

biosimilar drugs; inflammatory bowel disease; treatment perception

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Medicamentos Biossimilares / Gastroenterologistas Tipo de estudo: Observational_studies / Prevalence_studies / Qualitative_research / Risk_factors_studies Limite: Female / Humans / Pregnancy País/Região como assunto: Asia Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google